Efficacy of Brahmi vati and Aswagandharista in major depressive disorder: A randomized controlled trial

Efficacy of Brahmi vati and Aswagandharista in major depressive disorder: A randomized controlled trial

Background: Role of Ayurveda medications in the management of Major depressive disorder (MDD) is explored. Objective: To evaluate the effect of Brahmi vati and Aswagandarista in the management of MDD. Methods: Study was a Randomized, Controlled, parallel group comparative clinical trial. Fifty patie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amit Sarhyal, Sameeran Chate, Basavaraj R. Tubaki, Rajat Thakur
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Journal of Ayurveda and Integrative Medicine
Subjects:	Ayurveda Major depressive disorder Brahmi vati Aswagandharista Escitalopram
Online Access:	http://www.sciencedirect.com/science/article/pii/S0975947624001372
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of ayurveda medications, Brahmi vati and Saraswatarista, in generalized anxiety disorder- a randomized controlled trial
by: Varsha B. Gonugade, et al.
Published: (2024-11-01)

Comparison of the Effect of Sertraline and Escitalopram on the Treatment of Major Depressive Disorder in Hemodialysis Patients: A Randomized Controlled Trial
by: Tahereh Sabaghian, et al.
Published: (2024-09-01)

C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study
by: Ather Muneer, et al.
Published: (2023-12-01)

A prospective hospital-based study on C-reactive protein as a response predictor of antidepressant treatment in drug naïve patients with major depressive disorder
by: Didakamiwan Khonglah, et al.
Published: (2023-04-01)

Growth Attributes and Economics of Brahmi (Bacopa monnieri L.) Cultivation Influenced by Organic Sources of Nutrients
by: N. Vikram, et al.
Published: (2023-11-01)

A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality
by: Ye X, et al.
Published: (2024-12-01)

Ankle edema after administration of selective serotonin reuptake inhibitors
by: Konstantinos Kontoangelos, et al.
Published: (2018-06-01)

Potential Role of Ayurveda Interventions in the Management of Grade II Non Alcoholic Fatty Liver Disease: A Case Report
by: Babita Yadav, et al.
Published: (2024-12-01)

Predictive Value of Inflammatory Biomarkers in Assessing Major Depression in Adults
by: Radu Gavril, et al.
Published: (2024-10-01)

Insomnia Catastrophizing and Affective Temperaments in Major Depressive Disorder
by: Hilal Sezer Soylu, et al.
Published: (2024-09-01)

Efficacy of Mamsyadi Ghana capsule in Insomnia Disorder – A randomized controlled trial
by: Niranjan A. Kedar, et al.
Published: (2024-11-01)

Neuroinflammation and major depressive disorder: astrocytes at the crossroads
by: Melissa Puentes-Orozco, et al.
Published: (2024-11-01)

Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action
by: Juwairiah Remali, et al.
Published: (2024-10-01)

Oxidative alterations in exfoliated oral mucosa cells of patients with major depressive disorder
by: Lukas Mendes de Abreu, et al.
Published: (2025-03-01)

Association of inflammation cytokines with cognitive function in first-episode major depressive disorder
by: Yan Qing Xi, et al.
Published: (2025-01-01)

Pre- and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study
by: Delia Ibáñez, et al.
Published: (2024-11-01)

Gender differences of neurometabolic and neuroendocrine alternations and its lateralization in adolescents with major depressive disorder
by: Xiaodong Song, et al.
Published: (2024-12-01)

A Comparison of Sexual Dysfunctions in Female Patients with Major Depressive Disorder and Panic Disorder
by: Tonguç Demir Berkol, et al.
Published: (2014-08-01)

Dataset of Centella Asiatica leaves for quality assessment and machine learning applicationsMendeley Data
by: Rohini Jadhav, et al.
Published: (2024-12-01)

Vegetable intake and major depressive disorder: insights and future directions for nutritional psychiatry
by: John Patrick C Toledo
Published: (2025-01-01)

Recent advances in teaching–learning methodologies of the Ayurveda education system
by: Bhagyashree Jibkate, et al.
Published: (2024-11-01)

Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?
by: Monika Makar, et al.
Published: (2025-01-01)

Associations between dairy and alcohol consumption and major depressive disorder in a mendelian randomization study
by: Dan Qiu, et al.
Published: (2024-11-01)

Using hierarchical drift diffusion models to elucidate computational mechanisms of reduced reward sensitivity in adolescent major depressive disorder
by: Lei Shen, et al.
Published: (2024-12-01)

Associations of Schizophrenia and Major Depressive Disorder with Constipation: A Mendelian Randomization Study
by: Liu J, et al.
Published: (2024-11-01)

Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumResearch in context
by: Thuy-Dung Nguyen, et al.
Published: (2025-02-01)

Comparing the Efficacy of Escitalopram with and without Crocin in Restoring I/O Functions and LTP within the Hippocampal CA1 Region of Stressed Rats
by: Mehran Joodaki, et al.
Published: (2024-11-01)

Obsessive-compulsive disorder, major depressive disorder, and addiction: the vicious relationship
by: Rifaat S. El-Mallakh, et al.
Published: (2024-11-01)

Discriminant analysis of occupational performance characteristics in patients with major depressive disorders and healthy individuals
by: Tomonari Hayasaka, et al.
Published: (2024-12-01)

Association between prescriber practices and major depression treatment outcomes
by: Sarah Rathnam, et al.
Published: (2024-12-01)

Electroencephalographic markers in Major Depressive Disorder: insights from absolute, relative power, and asymmetry analyses
by: Mehmet Akif Özçoban, et al.
Published: (2025-01-01)

Motivators and barriers to help-seeking and treatment adherence in major depressive disorder: A patient perspective
by: Rahn K. Bailey, et al.
Published: (2024-12-01)

Immediate and sustained efficacy of Deep Brain Stimulation for major depressive disorder with persistent suicidal ideation
by: Botao Xiong, et al.
Published: (2025-02-01)

The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
by: Wenli Jiao, et al.
Published: (2025-01-01)

Effects of therapeutic alliance on patients with major depressive disorder: a literature review
by: Giovanni Videtta, et al.
Published: (2025-01-01)

Functional connectivity density of different suicidal behaviors in adolescents with major depressive disorders
by: Hui Zhong, et al.
Published: (2024-11-01)

Stacked ensemble machine learning approach for electroencephalography based major depressive disorder classification using temporal statistics
by: Nader Nisar Ahmed, et al.
Published: (2024-12-01)

AGEADJUSTED NORMATIVE DATA AND DISCRIMINATIVE VALIDITY OF COGNITIVE TESTS IN THE UKRAINIAN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER
by: O. S. Troyan
Published: (2021-07-01)

Elevated remnant cholesterol and the risk of prevalent major depressive disorder: a nationwide population-based study
by: Shiyi Tao, et al.
Published: (2024-11-01)

Association and interaction between overweight/obesity and suicide attempts in young first-episode and drug-naïve patients with major depressive disorder
by: Quanfeng Zhu, et al.
Published: (2024-11-01)